These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 10949931

  • 1. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells.
    Lee TH, Chuang LY, Hung WC.
    Oncogene; 2000 Aug 03; 19(33):3766-73. PubMed ID: 10949931
    [Abstract] [Full Text] [Related]

  • 2. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.
    Lee TH, Chuang LY, Hung WC.
    Oncogene; 1999 Jul 22; 18(29):4269-74. PubMed ID: 10435640
    [Abstract] [Full Text] [Related]

  • 3. Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells.
    Kim CG, Choi BH, Son SW, Yi SJ, Shin SY, Lee YH.
    Cell Signal; 2007 Jun 22; 19(6):1290-300. PubMed ID: 17307334
    [Abstract] [Full Text] [Related]

  • 4. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
    Liu Z, Shi HY, Nawaz Z, Zhang M.
    Cancer Lett; 2004 Jun 08; 209(1):55-65. PubMed ID: 15145521
    [Abstract] [Full Text] [Related]

  • 5. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
    Huang L, Sowa Y, Sakai T, Pardee AB.
    Oncogene; 2000 Nov 23; 19(50):5712-9. PubMed ID: 11126357
    [Abstract] [Full Text] [Related]

  • 6. Expression of cyclin D3 through Sp1 sites by histone deacetylase inhibitors is mediated with protein kinase C-delta (PKC-delta) signal pathway.
    Kim YH, Lim JH, Lee TJ, Park JW, Kwon TK.
    J Cell Biochem; 2007 Jul 01; 101(4):987-95. PubMed ID: 17407153
    [Abstract] [Full Text] [Related]

  • 7. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells.
    Xiao H, Hasegawa T, Isobe K.
    J Cell Biochem; 1999 Jun 01; 73(3):291-302. PubMed ID: 10321829
    [Abstract] [Full Text] [Related]

  • 8. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 01; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 9. As2O3-induced c-Src/EGFR/ERK signaling is via Sp1 binding sites to stimulate p21WAF1/CIP1 expression in human epidermoid carcinoma A431 cells.
    Liu ZM, Huang HS.
    Cell Signal; 2006 Feb 01; 18(2):244-55. PubMed ID: 15961274
    [Abstract] [Full Text] [Related]

  • 10. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
    Lou Z, Maher VM, McCormick JJ.
    Gene; 2005 May 23; 351():51-9. PubMed ID: 15857802
    [Abstract] [Full Text] [Related]

  • 11. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y, Chen S.
    Cancer Res; 2003 Jul 01; 63(13):3546-55. PubMed ID: 12839940
    [Abstract] [Full Text] [Related]

  • 12. Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells.
    Wang Z, Kyo S, Maida Y, Takakura M, Tanaka M, Yatabe N, Kanaya T, Nakamura M, Koike K, Hisamoto K, Ohmichi M, Inoue M.
    Oncogene; 2002 May 16; 21(22):3517-24. PubMed ID: 12032853
    [Abstract] [Full Text] [Related]

  • 13. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.
    Mandlekar S, Yu R, Tan TH, Kong AN.
    Cancer Res; 2000 Nov 01; 60(21):5995-6000. PubMed ID: 11085519
    [Abstract] [Full Text] [Related]

  • 14. Involvement of PKA and Sp1 in the induction of p27(Kip1) by tamoxifen.
    Lee TH, Chang HC, Chuang LY, Hung WC.
    Biochem Pharmacol; 2003 Aug 01; 66(3):371-7. PubMed ID: 12907235
    [Abstract] [Full Text] [Related]

  • 15. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T, Matsuzaki Y, Miyazawa K, Zindy F, Roussel MF, Sakai T.
    Oncogene; 2004 Jul 08; 23(31):5340-9. PubMed ID: 15107822
    [Abstract] [Full Text] [Related]

  • 16. Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance.
    Johnston SR, Lu B, Scott GK, Kushner PJ, Smith IE, Dowsett M, Benz CC.
    Clin Cancer Res; 1999 Feb 08; 5(2):251-6. PubMed ID: 10037172
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.
    Heegaard AM, Xie Z, Young MF, Nielsen KL.
    J Cell Biochem; 2004 Oct 15; 93(3):463-75. PubMed ID: 15372625
    [Abstract] [Full Text] [Related]

  • 18. 17beta-estradiol (E2) induces cdc25A gene expression in breast cancer cells by genomic and non-genomic pathways.
    Ru Lee W, Chen CC, Liu S, Safe S.
    J Cell Biochem; 2006 Sep 01; 99(1):209-20. PubMed ID: 16598773
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA, Oza BP, Atlas E, Verma VA, Mehmi I, Lupu R.
    Oncogene; 2004 Jun 17; 23(28):4945-58. PubMed ID: 15094777
    [Abstract] [Full Text] [Related]

  • 20. KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1.
    Wu J, Lingrel JB.
    Oncogene; 2004 Oct 21; 23(49):8088-96. PubMed ID: 15361832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.